Literature DB >> 22573592

Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics.

Claudia M Denkinger1, Jasmine Grenier, Jessica Minion, Madhukar Pai.   

Abstract

Laboratorians and clinicians often rely on package inserts of diagnostic tests to assess their accuracy. We compared test accuracy for tuberculosis diagnostics reported in 19 package inserts against estimates in published meta-analyses and found that package inserts generally report overoptimistic accuracy estimates. However, package inserts of most tests approved by the U.S. Food and Drug Administration (FDA) or endorsed by the World Health Organization provide more realistic estimates that agree with meta-analyses.

Entities:  

Mesh:

Year:  2012        PMID: 22573592      PMCID: PMC3405594          DOI: 10.1128/JCM.00842-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

2.  Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

Authors:  Kai Chang; Weiping Lu; Junji Wang; Kejun Zhang; Shuangrong Jia; Fake Li; Shaoli Deng; Ming Chen
Journal:  J Infect       Date:  2012-02-27       Impact factor: 6.072

Review 3.  Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Authors:  S Greco; E Girardi; A Navarra; C Saltini
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

4.  GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.

Authors:  D I Ling; A A Zwerling; M Pai
Journal:  Eur Respir J       Date:  2008-07-09       Impact factor: 16.671

Review 5.  A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.

Authors:  J Dinnes; J Deeks; H Kunst; A Gibson; E Cummins; N Waugh; F Drobniewski; A Lalvani
Journal:  Health Technol Assess       Date:  2007-01       Impact factor: 4.014

6.  Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-01-16       Impact factor: 17.586

Review 7.  T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.

Authors:  Keertan Dheda; Richard van Zyl Smit; Motasim Badri; Madhukar Pai
Journal:  Curr Opin Pulm Med       Date:  2009-05       Impact factor: 3.155

Review 8.  A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

Authors:  Maureen Morgan; Shriprakash Kalantri; Laura Flores; Madhukar Pai
Journal:  BMC Infect Dis       Date:  2005-07-28       Impact factor: 3.090

Review 9.  Bacteriophage- based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta- analysis.

Authors:  Shriprakash Kalantri; Madhukar Pai; Lisa Pascopella; Lee Riley; Arthur Reingold
Journal:  BMC Infect Dis       Date:  2005-07-16       Impact factor: 3.090

10.  Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Authors:  Daphne I Ling; Laura L Flores; Lee W Riley; Madhukar Pai
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

View more
  5 in total

1.  Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.

Authors:  Chang Liu; Zhen Zhao; Jia Fan; Christopher J Lyon; Hung-Jen Wu; Dobrin Nedelkov; Adrian M Zelazny; Kenneth N Olivier; Lisa H Cazares; Steven M Holland; Edward A Graviss; Ye Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 2.  Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Authors:  Claudia M Denkinger; David Dolinger; Marco Schito; William Wells; Frank Cobelens; Madhukar Pai; Matteo Zignol; Daniela Maria Cirillo; David Alland; Martina Casenghi; Jim Gallarda; Catharina C Boehme; Mark D Perkins
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

3.  Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries.

Authors:  Jacob Creswell; Andrew J Codlin; Emmanuel Andre; Mark A Micek; Ahmed Bedru; E Jane Carter; Rajendra-Prasad Yadav; Andrei Mosneaga; Bishwa Rai; Sayera Banu; Miranda Brouwer; Lucie Blok; Suvanand Sahu; Lucica Ditiu
Journal:  BMC Infect Dis       Date:  2014-01-02       Impact factor: 3.090

4.  Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis.

Authors:  Claudia M Denkinger; Yatiraj Kalantri; Samuel G Schumacher; Joy S Michael; Deepa Shankar; Arvind Saxena; Natarajan Sriram; Thangakunam Balamugesh; Robert Luo; Nira R Pollock; Madhukar Pai; Devasahayam J Christopher
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

5.  Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.

Authors:  Lukas E Brümmer; Stephan Katzenschlager; Mary Gaeddert; Christian Erdmann; Stephani Schmitz; Marc Bota; Maurizio Grilli; Jan Larmann; Markus A Weigand; Nira R Pollock; Aurélien Macé; Sergio Carmona; Stefano Ongarello; Jilian A Sacks; Claudia M Denkinger
Journal:  PLoS Med       Date:  2021-08-12       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.